(Q46182927)

English

Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology?

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

Fertility preservation for men with testicular cancer: Is sperm cryopreservation cost effective in the era of assisted reproductive technology? (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

cryopreservation

0 references

testicular cancer

1 reference

based on heuristic

inferred from title

object named as

Akanksha Mehta

5

0 references

author name string

Kirven Gilbert

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

Ajay K Nangia

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

James M Dupree

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

James F Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

language of work or name

1 reference

based on heuristic

inferred from title

publication date

20 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Testicular Cancer, Version 2.2015

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Male infertility in cancer patients: Review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Facilitators and obstacles to sperm banking in young men receiving gonadotoxic chemotherapy for cancer: the perspective of survivors and health care professionals

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Desire for children, difficulties achieving a pregnancy, and infertility distress 3 to 7 years after cancer diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Adolescent and young adult oncology. Clinical practice guidelines in oncology

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Fertility preservation in children, adolescents, and young adults with cancer: Quality of clinical practice guidelines and variations in recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Review and follow-up of patients using a regional sperm cryopreservation service: ensuring that resources are targeted to those patients most in need

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

High risk of azoospermia in men treated for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Endocrine and exocrine profiles of men with testicular tumors before orchiectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

The impact of testicular carcinoma and its treatment on sperm DNA integrity

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Fertility after chemotherapy for testicular germ cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years' experience.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Gonadal function after multimodality treatment in men with testicular germ cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Fertility after chemotherapy for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Semen quality before and after gonadotoxic treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Long-term recovery of spermatogenesis after radiotherapy in patients with testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Fertility in men after treatment for stage 1 and 2A seminoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Impact of chemotherapeutics and advanced testicular cancer or Hodgkin lymphoma on sperm deoxyribonucleic acid integrity

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Ejaculatory Status and Fertility Rates After Primary Retroperitoneal Lymph Node Dissection

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

A comparative analysis of robotic vs laparoscopic retroperitoneal lymph node dissection for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Fertility in men with testicular germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Paternity in men with stage I testis tumors on surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Fertility among testicular cancer survivors: a case-control study in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Sperm cryopreservation in oncological patients: a 14-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

"Onco-tese": testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Onco-testicular sperm extraction: testicular sperm extraction in azoospermic and very severely oligozoospermic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Microdissection testicular sperm extraction and salvage hormonal treatment in patients with postchemotherapy azoospermia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Intracytoplasmic sperm injection by testicular sperm in patients with aspermia or azoospermia after cancer treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Out-of-pocket fertility patient expense: data from a multicenter prospective infertility cohort.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Assisted reproductive technology and birth defects: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Semen quality of young adult ICSI offspring: the first results

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Young Men With Cancer Experience Low Referral Rates for Fertility Counseling and Sperm Banking

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2017.11.002

7 January 2021

Identifiers

10.1016/J.UROLONC.2017.11.002

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29169844

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46182927&oldid=1983859735"